The broad goals of the ADRC at Columbia University include creating an infrastructure for research on AD and related disorders, fostering interdisciplinary collaborations across many departments, providing a rich training environment, and supporting outreach and patient recruitment. More globally, the goals of our ADRC extend to include participation in all national coordinating efforts, working with the national network of AD centers, and working with the National Institute on Aging and other organizations in their advocacy efforts. Embedded within these broad goals, in this reapplication a concentration will be placed on better defining normal aging and the transition from normal aging to the earliest stages of AD. The Administrative Core will act as the executive governing body of the ADRC that, with the guidance of its various committees, will provide the vision and leadership necessary to achieve the ADRC s goals. The Administrative Core will implement this vision by exercising managerial oversight over all aspects of the ADRC, which includes assuring the highest standards of scientific and bioethical conduct and assuring a judicious use of resources and funds. Dr. Scott Small will lead the core together with Dr. Richard Mayeux (co-director of the ADRC), Drs. Lawrence Honig and Yaakov Stern (deputy directors of the ADRC), Ms. Rosann Costa (Administrator of the ADRC), and Mr. Kevin Ramratan (Financial coordinator of the ADRC). Together and through continuous meetings they will achieve the ADRC s goals via a number of specific aims. These include: 1) Organize and direct monthly meetings with an executive committee made up of all core and project leaders. 2) Work closely with an external and internal advisory committee revamped to better fit the updated goals of the ADRC. 3) Work closely with the other cores to assure timely delivery of high quality clinical, genetic, and neuroimaging data, as well as biospecimens, to national consortia. 4) Work closely with a newly assembled resource committee . 5) Work closely with a newly assembled pilot project committee . 6) Assure and enhance the ADRC s outreach, advocacy, education, and training mission.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
New York
United States
Zip Code
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Winawer, Melodie R; Griffin, Nicole G; Samanamud, Jorge et al. (2018) Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol 83:1133-1146
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Qureshi, Yasir H; Patel, Vivek M; Berman, Diego E et al. (2018) An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect. Mol Cell Biol 38:
Reitz, Christiane (2018) Retromer Dysfunction and Neurodegenerative Disease. Curr Genomics 19:279-288

Showing the most recent 10 out of 640 publications